Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP‐treated monkeys: Feasibility relevant to multiple‐target grafting as a therapy for Parkinson's disease
暂无分享,去创建一个
R. Roth | JaneR . Taylor | C. Sortwell | J. Elsworth | J. Sladek | T. Collier | D. Redmond
[1] Robert L. Mason,et al. Statistical Principles in Experimental Design , 2003 .
[2] M. Hong,et al. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: Role of the intranigral graft , 2000, The Journal of comparative neurology.
[3] R. Roth,et al. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment , 1999, Neuroscience.
[4] Ornella Rimoldi,et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient , 1999, Nature Neuroscience.
[5] C. Sortwell,et al. Therapeutic Potential of Nerve Growth Factors in Parkinson’s Disease , 1999, Drugs & aging.
[6] A. Björklund,et al. Intranigral Transplants of GABA-Rich Striatal Tissue Induce Behavioral Recovery in the Rat Parkinson Model and Promote the Effects Obtained by Intrastriatal Dopaminergic Transplants , 1999, Experimental Neurology.
[7] T. Itakura,et al. Intrastriatal Mesencephalic Grafts Affect Neuronal Activity in Basal Ganglia Nuclei and Their Target Structures in a Rat Model of Parkinson’s Disease , 1998, The Journal of Neuroscience.
[8] M. Hong,et al. Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using fluorogold and horseradish peroxidase , 1997, Brain Research.
[9] L. Olson,et al. Neurturin and Glial Cell Line-Derived Neurotrophic Factor Receptor-β (GDNFR-β), Novel Proteins Related to GDNF and GDNFR-α with Specific Cellular Patterns of Expression Suggesting Roles in the Developing and Adult Nervous System and in Peripheral Organs , 1997, The Journal of Neuroscience.
[10] R. Roth,et al. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus) , 1997, Neuroscience.
[11] D. Hilt,et al. ret receptor tyrosine kinase immunoreactivity is altered in glial cell line-derived neurotrophic factor-responsive neurons following lesions of the nigrostriatal and septohippocampal pathways. , 1997, Neuroscience.
[12] N. Belluardo,et al. Complementary and Overlapping Expression of Glial Cell Line-Derived Neurotrophic Factor (GDNF), c-ret Proto-Oncogene, and GDNF Receptor-α Indicates Multiple Mechanisms of Trophic Actions in the Adult Rat CNS , 1997, The Journal of Neuroscience.
[13] M. Radeke,et al. Immunocytochemical localization of TrkB in the central nervous system of the adult rat , 1997, The Journal of comparative neurology.
[14] D. Yurek. Intranigral Transplants of Fetal Ventral Mesencephalic Tissue Attenuate D1-Agonist-Induced Rotational Behavior , 1997, Experimental Neurology.
[15] B. Flumerfelt,et al. Effects of graft-derived dopaminergic innervation on the target neurons of patch and matrix compartments of the striatum , 1997, Neuroscience.
[16] M. Hong,et al. Reconstruction of the Nigrostriatal Pathway by Simultaneous Intrastriatal and Intranigral Dopaminergic Transplants , 1996, The Journal of Neuroscience.
[17] A. Buj-Bello,et al. Characterization of a multicomponent receptor for GDNF , 1996, Nature.
[18] E. Arenas,et al. Functional receptor for GDNF encoded by the c-ret proto-oncogene , 1996, Nature.
[19] E. Mufson,et al. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies , 1996, The Journal of comparative neurology.
[20] C. Olanow,et al. Fetal nigral transplantation as a therapy for Parkinson's disease , 1996, Trends in Neurosciences.
[21] C. Weickert,et al. GDNF mRNA expression in normal postnatal development, aging, and in weaver mutant mice , 1995, Neurobiology of Aging.
[22] A. Björklund,et al. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[23] D. Choi-Lundberg,et al. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. , 1995, Brain research. Developmental brain research.
[24] J. Greenamyre,et al. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[25] S. Wiegand,et al. Efficacy of Brain‐Derived Neurotrophic Factor and Neurotrophin‐3 on Neurochemical and Behavioral Deficits Associated with Partial Nigrostriatal Dopamine Lesions , 1994, Journal of neurochemistry.
[26] K. Fuxe,et al. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons , 1994, Neuroscience.
[27] T. Takeshima,et al. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[28] J. Trojanowski,et al. Expression of GDNF mRNA in Rat and Human Nervous Tissue , 1994, Experimental Neurology.
[29] Y. Sauve,et al. Astrocyte-dependent and -independent phases of the development and survival of rat embryonic day 14 mesencephalic, dopaminergic neurons in culture , 1994, Neuroscience.
[30] G. Nikkhah,et al. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] C. Gall,et al. Dopaminergic neurons in rat ventral midbrain express brain‐derived neurotrophic factor and neurotrophin‐3 mRNAs , 1994, The Journal of comparative neurology.
[32] I. Black,et al. Regional and Cell-Specific Expression of GDNF in Rat Brain , 1993, Experimental Neurology.
[33] C. Gall,et al. Expression of Neurotrophins by Midbrain Dopaminergic Neurons , 1993, Experimental Neurology.
[34] A. Bjo¨rklund,et al. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: Differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels , 1993, Neuroscience.
[35] D. Abrous,et al. Transplantation of fetal nigral cells reverses the increase of preproenkephalin mRNA levels in the rat striatum caused by 6-OHDA lesion of the dopaminergic nigrostriatal pathway: a quantitative in situ hybridization study. , 1993, Brain research. Molecular brain research.
[36] C. Mytilineou,et al. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP+-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF , 1992, Brain Research.
[37] P. Ernfors,et al. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system , 1992, Neuroscience.
[38] I. Tooyama,et al. High molecular weight basic fibroblast growth factor-like protein is localized to a subpopulation of mesencephalic dopaminergic neurons in the rat brain , 1992, Brain Research.
[39] H. Robertson,et al. Dopamine receptor interactions: some implications for the treatment of Parkinson's disease , 1992, Trends in Neurosciences.
[40] C. Gall,et al. Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons , 1992, Molecular and Cellular Neuroscience.
[41] D. Abrous,et al. Increase of striatal methionin enkephalin content following lesion of the nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons: A quantitative immunohistochemical analysis , 1991, Neuroscience.
[42] T. Hökfelt,et al. Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[43] L. Olson,et al. Cells that Express Brain‐Derived Neurotrophic Factor mRNA in the Developing Postnatal Rat Brain , 1991, The European journal of neuroscience.
[44] David C. Lee,et al. Regional expression of transforming growth factor-α mRNA in the rat central nervous system , 1991, Neuroscience Letters.
[45] R. Penn,et al. Putative chromaffin cell survival and enhanced host‐derived TH‐Fiber innervation following a functional adrenal medulla autograft for Parkinson's disease , 1991, Annals of neurology.
[46] S. Dunnett,et al. Increased proenkephalin mRNA levels in the rat neostriatum following lesion of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): reversal by embryonic nigral dopamine grafts. , 1991, Brain research. Molecular brain research.
[47] D. Bonthron,et al. PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model , 1991, Cell.
[48] E. Oldfield,et al. Long-term evaluation of hemiparkinsonian monkeys after adrenal autografting or cavitation alone. , 1990, Journal of neurosurgery.
[49] W. Freed,et al. Intracerebral adrenal medulla grafts: A review , 1990, Experimental Neurology.
[50] H. Bergman,et al. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.
[51] Y. Barde,et al. Regional distribution of brain‐derived neurotrophic factor mRNA in the adult mouse brain. , 1990, The EMBO journal.
[52] M. Delong,et al. Primate models of movement disorders of basal ganglia origin , 1990, Trends in Neurosciences.
[53] I. Date,et al. Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice , 1990, Experimental Neurology.
[54] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[55] R. Roth,et al. Symptomatic and asymptomatic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated primates: Biochemical changes in striatal regions , 1989, Neuroscience.
[56] J. Kordower,et al. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: Graft viability and fine structure , 1988, Experimental Neurology.
[57] J. Kordower,et al. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: Injury-induced regeneration , 1988, Experimental Neurology.
[58] G. Bing,et al. Comparison of adrenal medullary, carotid body and PC12 cell grafts in 6-OHDA lesioned rats , 1988, Brain Research Bulletin.
[59] D. Gash,et al. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. , 1987, Science.
[60] R. Roth,et al. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF , 1987, Brain Research.
[61] J. Marshall,et al. Altered succinate dehydrogenase activity of basal ganglia following damage to mesotelencephalic dopaminergic projection , 1981, Brain Research.
[62] J. Glowinski,et al. Dendritic release of dopamine in the substantia nigra , 1981, Nature.
[63] T. Jessell,et al. Release of dopamine from dendrites in rat substantia nigra , 1976, Nature.
[64] M. Abercrombie. Estimation of nuclear population from microtome sections , 1946, The Anatomical record.
[65] R. Roth,et al. Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys. , 1995, Cell transplantation.
[66] R. Roth,et al. Behavioral Effects of MPTP Administration in the Vervet Monkey , 1994 .
[67] V. Han,et al. Regional expression of transforming growth factor-alpha mRNA in the rat central nervous system. , 1991, Neuroscience letters.
[68] K. M. Sweeney,et al. Preliminary report on adrenal medullary grafting and cografting with sural nerve in the treatment of hemiparkinson monkeys. , 1990, Progress in brain research.
[69] G. Bing,et al. Paraneuronal grafts in unilateral 6-hydroxydopamine-lesioned rats: morphological aspects of adrenal chromaffin and carotid body glomus cell implants. , 1988, Progress in brain research.
[70] D. Jacobowitz,et al. Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts. , 1988, Progress in brain research.